Protocol summary

Study aim
To compare the effectiveness of administration of the one third of intraoperative fluid with standard amount of fluid on pulmonary complications after lobectomy of left lung
Design
This randomized and double-blind clinical trial with parallel and control groups will be conducted on 140 patients who will be randomly selected using the random number table.
Settings and conduct
Patients candidate for lobectomy of left lung referring to Ghaem Hospital, Mashhad, Iran are chosen as the participants of the study. In this double-blind study, sealed opaque envelopes will be used to conceal the sequencing. Intervention group will receive the one third of intraoperative fluid and control will receive standard amount of fluids. The participants and responsible for data collection are blind to group allocation and the type of intervention.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients with ASA I, II or III, who are candidate for lobectomy of left lung; not having cardiovascular disease; not having kidney failure; not having systemic disease such as diabetes, hypertension and thyroid disease. Exclusion criteria: Receiving high intraoperative blood transfusion volume greater than 50 percent of the total blood volume of patient during three hours; receiving diuretics and osmotic substances before surgery; patient cardiopulmonary arrest.
Intervention groups
The intervention group will receive midazolam, fentanyl and propofol to induce anesthesia, then will receive one third of fluid maintenance during surgery. The control group will receive midazolam, fentanyl and propofol to induce anesthesia, then will receive standard rate of fluid maintenance during surgery.
Main outcome variables
Evaluation the total fluid rate injection during intraoperative, duration of anesthesia, duration of hospitalization, pulmonary complications and mortality rate.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220627055294N1
Registration date: 2022-06-30, 1401/04/09
Registration timing: prospective

Last update: 2022-06-30, 1401/04/09
Update count: 0
Registration date
2022-06-30, 1401/04/09
Registrant information
Name
Mandana Jahanian
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3840 0000
Email address
jahanianm991@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-08-23, 1401/06/01
Expected recruitment end date
2023-08-23, 1402/06/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
A clinical trial to compare the effectiveness of administration of the one third of intraoperative fluid with standard amount of fluid on pulmonary complications after lobectomy of left lung
Public title
The effectiveness of the amount of intraoperative fluid administration on pulmonary complications after lobectomy of left lung
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with ASA I, II or III, who are candidate for lobectomy of left lung Not having cardiovascular disease Not having kidney failure Not having systemic disease such as diabetes, hypertension and thyroid disease
Exclusion criteria:
Receiving high intraoperative blood transfusion volume greater than 50 percent of the total blood volume of patient during three hours Receiving diuretics and osmotic substances before surgery Patient cardiopulmonary arrest
Age
No age limit
Gender
Both
Phase
2-3
Groups that have been masked
  • Care provider
  • Outcome assessor
Sample size
Target sample size: 140
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, simple randomization will be used by random number table based on SAS (statistical analysis system), software. A list of sequentially number 1 to 10 will be created. This list will assign numbers randomly by computer. Patients are randomly assigned according to the numbers of this list. To conceal, we use allocation concealment, using non-transparent envelopes sealed with random sequences (Sequentially numbered, sealed, opaque envelopes). They are placed in order. In order to maintain the random sequence, numbering is done on the outer surface of the envelopes in the same way. Finally, the lids of the envelopes are glued and placed inside a box, respectively. At the beginning of the registration of participants, based on the order of entry of eligible participants in the study, one of the envelopes will be opened in order and the assigned group of the participant will be revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients candidate for lobectomy of left lung referring to Ghaem Hospital, Mashhad, Iran are chosen as the participants of the study. In this double-blind study, sealed opaque envelopes will be used to conceal the sequencing. Intervention group will receive the one third of intraoperative fluid and control will receive standard amount of fluids. The participants and responsible for data collection are blind to group allocation and the type of intervention.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Mashhad University of Medical Sciences
Street address
Vice Chancellor for Research, Mashhad University of Medical Sciences, Ghoreishi building, Daneshgah Street
City
Mashhad
Province
Razavi Khorasan
Postal code
9195965919
Approval date
2022-05-31, 1401/03/10
Ethics committee reference number
IR.MUMS.MEDICAL.REC.1401.176

Health conditions studied

1

Description of health condition studied
Pulmonary complications after lobectomy
ICD-10 code
J95.3
ICD-10 code description
Chronic pulmonary insufficiency following surgery

Primary outcomes

1

Description
The total fluid rate injection during intraoperative
Timepoint
During surgery
Method of measurement
Total volume of injected fluids in cc per kg

2

Description
Duration of anesthesia
Timepoint
After intervention
Method of measurement
The number of hours of postoperative anesthesia

3

Description
The duration of hospitalization
Timepoint
Two weeks after intervention
Method of measurement
The number days of hospitalization

4

Description
Pulmonary complications (acute respiratory distress syndrome, intubation, atelectasis, pneumonia, persistent air leaks)
Timepoint
48 hours after intervention
Method of measurement
Based on clinical examinations

5

Description
Mortality rate
Timepoint
48 hours after intervention
Method of measurement
Calculating a mortality rate

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: The intervention group will receive midazolam, fentanyl and propofol to induce anesthesia, then will receive one third of fluid maintenance during surgery.
Category
Prevention

2

Description
Control group: The control group will receive midazolam, fentanyl and propofol to induce anesthesia, then will receive standard rate of fluid maintenance during surgery.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Ghaem Hospital
Full name of responsible person
Mandana Jahanian
Street address
Ghaem Hospital, Ahmadabad Street, Dr. Ali Shariati Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 51 3840 0000
Email
jahanianm991@mums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaghodi
Street address
Vice Chancellor for Research, Mashhad University of Medical Sciences, Ghoreishi building, Daneshgah Street
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3841 1538
Email
vcresearch@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mandana Jahanian
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ghaem Hospital, Ahmadabad Street, Dr. Ali Shariati Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913316
Phone
+98 51 3840 0000
Email
jahanianm991@mums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mandana Jahanian
Position
Resident
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ghaem Hospital, Ahmadabad Street, Dr. Ali Shariati Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913316
Phone
+98 51 3840 0000
Email
jahanianm991@mums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mandana Jahanian
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ghaem Hospital, Ahmadabad Street, Dr. Ali Shariati Square
City
Mashhad
Province
Razavi Khorasan
Postal code
9137913316
Phone
+98 51 3840 0000
Email
jahanianm991@mums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
The research data obtained from the main outcomes of the study can be shared freely as 'open data'.
When the data will become available and for how long
6 months after publishing the results
To whom data/document is available
The research data is exclusively accessible to the researchers working at universities and centers for scientific research.
Under which criteria data/document could be used
The research data is exclusively accessible to the researchers working at universities and centers for scientific research.
From where data/document is obtainable
Mandana Jahanian provides the data analysis to the applicants via email: jahanianm991@mums.ac.ir
What processes are involved for a request to access data/document
Applicants can send emails to him and receive a response within a week.
Comments
Loading...